AssetMark Inc’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

AssetMark Inc’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5	Closed	–	–	1576
2022 Q1	$0	Buy	+5	New	+$177	﹤0.01%	1649

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

AssetMark Inc's IDNA Position: Q2 2022 in Review

AssetMark Inc sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2022, closing a stake of 5 shares.

AssetMark Inc first reported a position in IDNA in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 73 funds tracked by Wall St. Rank hold IDNA as of Q2 2022.

AssetMark Inc reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2022 after selling out during the quarter.
AssetMark Inc sold 5 iShares Genomics Immunology and Healthcare ETF shares in Q2 2022.
AssetMark Inc first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2022 and held it in 1 quarter.
AssetMark Inc's iShares Genomics Immunology and Healthcare ETF position peaked at $0 in Q1 2022.
73 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2022.

Based on AssetMark Inc's 13F filing for Q2 2022, filed 3 Aug 2022.